Cosmos Health authorizes up to $5M share repurchase program, representing ~50% of market cap

Cosmos Health Inc.

Board authorized repurchase of up to $5M of common stock over 6 months ending Dec 31, 2026.
CEO cites record revenue, improving margins, US expansion, and animal healthcare entry as confidence drivers.
Program size equals nearly half of market capitalization as of June 29, 2026.
Repurchases may be made via open market, private transactions, or Rule 10b5-1 plans.
Timing and amount depend on market conditions, price, and regulatory requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.